A former manager at Genentech claims the company bypassed ethical and clinical guidelines in order to rush a promising drug through clinical trials.
Daily News Roundup
A former manager at Genentech claims the company bypassed ethical and clinical guidelines in order to rush a promising drug through clinical trials.
A researcher from the John Wayne Cancer Institute has settled his scientific misconduct case with the Office of Research Integrity.
Australian trout are susceptible to skin cancer, according to a new study—the first evidence that wild fish can be afflicted by the disease.
An approved cancer therapeutic makes hiding HIV susceptible to antiviral therapy.
The first full computer model of a single-celled organism mimics the bacterium’s behaviors and paves the way to more complete disease models.
Rather than rely on plant-derived products, biotech companies are engineering bacteria and yeast to produce ingredients for fragrances.
A trial comparing the effectiveness of robotic surgery and radiation for the treatment of throat cancer has begun in Canada.
Peptides extracted from scorpion venom fights off drug-resistant bacterial infections in mice.
Wales creates a database of DNA barcodes for all of its native flowering plants, hoping to guide conservation and drug development efforts.
Protesters crash the BIO conference to protest the delayed approval of a breast cancer drug.